Li G
- Sensory Systems top 10%
-
- Cancer-related molecular mechanisms research 8
- Cancer, Hypoxia, and Metabolism 5
-
- RNA modifications and cancer 10
- Cancer-related gene regulation 7
-
- Sarcoma Diagnosis and Treatment 4
-
- Lymphoma Diagnosis and Treatment 4
-
- Multiple and Secondary Primary Cancers 4
-
- Drug Transport and Resistance Mechanisms 4
- Journals
- Journal of the American Society of Nephrology (1 paper)Respirology (1 paper)SHILAP Revista de lepidopterología (21 papers)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Li G
162 papers receiving 611 citations
Peers
Comparison fields: 5 of 127
- Sensory Systems 28
- Cancer Research 68
- Developmental Neuroscience 16
- Neurology 31
- Neurology 53
Countries citing papers authored by Li G
This map shows the geographic impact of Li G's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li G with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li G more than expected).
Fields of papers citing papers by Li G
This network shows the impact of papers produced by Li G. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li G. The network helps show where Li G may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li G, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The Immune-Related Gene ELF3 is a Novel Biomarker for the Prognosis of Ovarian Cancer | 2021 | 1 |
| 2 | Release and Actions of Inflammatory Exosomes in Pulmonary Emphysema: Potential Therapeutic Target of Acupuncture | 2021 | 1 |
| 3 | Metformin Promotes Beclin1-Dependent Autophagy to Inhibit the Progression of Gastric Cancer | 2020 | 2 |
| 4 | A Novel Circular RNA, circ_0005394, Predicts Unfavorable Prognosis and Contributes to Hepatocellular Carcinoma Progression by Regulating miR-507/E2F3 and miR-515-5p/CXCL6 Signaling Pathways | 2020 | 0 |
| 5 | Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas | 2020 | 4 |
| 6 | Hsa_circ_0046263 Drives the Carcinogenesis and Metastasis of Non-Small Cell Lung Cancer Through the Promotion of NOVA2 by Absorbing Mir-940 as a Molecular Sponge | 2020 | 1 |
| 7 | Dual Targeting of Cell Growth and Phagocytosis by Erianin for Human Colorectal Cancer | 2020 | 1 |
| 8 | Resistance Mechanism of PD-1/PD-L1 Blockade in the Cancer-Immunity Cycle | 2020 | 1 |
| 9 | Mannose Suppresses the Proliferation and Metastasis of Lung Cancer by Targeting the ERK/GSK-3β/β-Catenin/SNAIL Axis | 2020 | 1 |
| 10 | The prognosis and changes of regional brain gray matter volume in MDD with gastrointestinal symptoms | 2019 | 1 |
| 11 | Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell proliferation by activating PI3K/AKT pathway in hepatocellular carcinoma | 2019 | 1 |
| 12 | Pandoraea sputorum Bacteremia In A Patient Who Had Undergone Allogeneic Liver Transplantation Plus Immunosuppressive Therapy: A Case Report | 2019 | 1 |
| 13 | Prognostic value of long non-coding RNA CRNDE in gastrointestinal cancers: a meta-analysis | 2019 | 2 |
| 14 | Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer | 2019 | 3 |
| 15 | Impact of CXCR4 and CXCR7 knockout by CRISPR/Cas9 on the function of triple-negative breast cancer cells | 2019 | 3 |
| 16 | Successful treatment of relapsed testicular embryonal rhabdomyosarcoma with Endostar and traditional chemotherapy: a case report | 2018 | 1 |
| 17 | New standardized nursing cooperation workflow to reduce stroke thrombolysis delays in patients with acute ischemic stroke | 2017 | 1 |
| 18 | A combination of functional magnetic resonance imaging and diffusion tensor image to explore structure–function relationship in healthy and myelopathic spinal cord | 2016 | 1 |
| 19 | [Guideline for diagnosis and treatment of ALK positive non-small cell lung cancer in China]. | 2015 | 3 |
| 20 | [Expression of CerbB-2 and EGFR mRNA in human nasopharyngeal carcinomas and pericarcinomatous tissues]. | 1997 | 4 |
About Li G
Li G is a scholar working on Anatomy, Cancer Research, Oncology, Pathology and Forensic Medicine and Complementary and alternative medicine, having authored 175 papers that have together received 632 indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (8 papers), Cancer-related gene regulation (7 papers), Cancer, Hypoxia, and Metabolism (5 papers), Sarcoma Diagnosis and Treatment (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Multiple and Secondary Primary Cancers (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Sensory Systems (28 citations), Cancer Research (68 citations), Developmental Neuroscience (16 citations), Neurology (31 citations) and Neurology (53 citations). Li G has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Youhua Xie, Li He, Zhiwei Zhu, Ke Xu, Xinghua Pan, Youli Hu, Paul E. Micevych, Iván A. López, Honrubia and Zhang Yj. Their work appears in journals such as Journal of the American Society of Nephrology, Respirology, SHILAP Revista de lepidopterología, iForest - Biogeosciences and Forestry and Acta Mathematicae Applicatae Sinica English Series.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.